Fatih YETİŞGİN, Ramazan ESEN, Mustafa BİLİCİ

Evaluation of Serum Levels of Trace Elements in Myeloproliferative Neoplasms: A Case-Control Study

The lack or excess of some of trace elements or heavy metals could be associated with the risk of hematologic malignancy. This study aimed to compare the patients with myeloproliferative neoplasm with the serum concentrations of Zinc (Zn), copper (Cu), manganese (Mn), nickel (Ni), lead (Pb), iron (Fe), cadmium (Cd) and cobalt (Co) in healthy individuals. Healthy individuals in the control group and newly diagnosed patients with myeloproliferative neoplasm were involved in the research. The patient and control groups were similar in terms of socioeconomic status and eating habits. The serum levels of the trace elements were determined via Atomic Absorption Spectrophotometry. The myeloproliferative neoplasm group consisted of 60 patients while the control group consisted of 20 volunteers. In the patient group, serum Zn and Fe concentrations were significantly lower than the control group (p=0.001 and p=0.001). Serum Cu, Pb, Cd, Co, Ni and Mn concentrations were higher in the patient group (p=0.001, p=0.001, p=0.001, p=0.001, p=0.001, p=0.027, respectively). When a comparison was made between Mn serum level and the control group, Mn serum level was determined to be low in PMF (p>5%). Serum Cd and Ni levels were higher in PMF, ET, CML and PV (p=0.005). Pb serum level was higher in ET, CML and PV (p=0.001, p=0.001, p=0.001, respectively). Serum Fe and Zn levels were lower in the PMF, ET, CML and PV groups (p=0.001 and p >0.5, respectively, for Fe). Serum Zn and Fe levels were lower and Cu, Pb, Cd, Co, Ni and Mn levels were higher in patients with myeloproliferative neoplasm. In particular, Zn is a very strong antioxidant element, and the fact that Zn is low in patients suggests that it could be an important marker in PV, ET, CML and PMF cases.

PDF

___

1. Abkowitz JL, Catlin SN, Guttorp P. Evidence that hematopoiesis may be a stochastic process in vivo. Nat Med 1996; 2: 190.

2. Zuo XL, Chen JM, Zhou X, Li XZ, Mei GY. Levels of selenium, zinc, copper, and antioxidant enzyme activity in patients with leukemia. Biol Trace Elem Res 2006; 114: 41-53.

3. Chang LW, Magos L, Suzuki T. Toxicology of Metals. Boca Raton. FL, USA: CRC Press; 1996.

4. Aldor Y, Walach N, Modai D, Horn Y. Zinc and copper levels in plasma, erythrocytes, and whole blood in cancer patients. Klin Wochenschr 1982; 60: 375-377.

5. Olivares M, Uauy R. Copper as an essential nutrient. Am J Clin Nutr 1996; 63: 791-796.

6. Gupte A, Mumper RJ. Elevated copper and oxidative stress in cancer cells as a target for cancer treatment. Cancer Treat Rev 2009; 35: 32-46.

7. Demir C, Demir H, Esen R, Sehitogullari A, Atmaca M, Alay M. Altered serum levels of elements in acute leukemia cases in Turkey. Asian Pac J Cancer 2011; 12: 3471-3474.

8. Akanni EO, Onuegbu AJ. Assessment of Some Selected Trace Metals in Chronic Myeloid Leukemia Patients in a Tertiary Health Facility in South West Nigeria. Asian J Med Sci 2013; 5: 71-75.

9. Tadmor T, Bejar J. The expression of lysyl-oxidase gene family members in myeloproliferative neoplasms. Am J Hematol 2013; 88: 355-358.

10. Spangler JG, Reid JC. Environmental Manganese and Cancer Mortality Rates by County in North Carolina: An Ecological Study. Biol Trace Elem Res 2010; 133: 128-135.

11. Sunderman FW, Lau TJ, Cralley LJ. Inhibitory Effects of Manganese Upon Muscle Immunogenesis by Nickel Sulfide. Cancer Res 974; 34: 92-95.

12. Marklund S. Purification and Characterization of a Manganese Containing Superoxide Dismutase from Bovine Heart Mitochondria. Int J Biochem 1978; 9: 299-306.

13. Wen CG, Pang GY, Huang SQ. Significance of the serum level of Cu, Zn, Mn, Cr and Ni in acute leukemia. Zhonghua nei ke za zhi 1989; 28: 734-736.

14. Wang YH, Xu XJ, Zhang LF, Li HL. Mimic of manganese superoxide dismutase induces apoptosis in human acute myeloid leukemia cells. Leuk Lymphoma 2014; 55: 1166-1175.

15. Vydyborets SV, Tishchenko LM. The chemical element content of the erythrocytes in polycythemia vera. Vrachebnoe Delo 1989; 10: 80-81.

16. Rose J. (Ed.). Trace elements in health: A review of current issues, Butterworth-Heineman, 1983.

17. Reddy BS, Charles JM, Raju NJG, Vijayan V, Reddy SB, Kumar RM, Sundareswar B. Trace elemental analysis of carcinoma kidney and stomach by PIXE method. Nucl Instr Methods Phys Res B 2003; 207: 345-355.

18. Ghandour MA, Thabet AF, Mohamed R. Determination of Zinc, Copper, Cadmium and Lead in Serum of Patients with Acute Leukemia. J Environ Sci Toxicol Food Technol 2013; 5: 66-76.

19. IARC. Monographs on the Evaluation of Carcinogenic Risk of Chemicals to Man. Vol. 23, IARC, Lyon, in press.

20. Cooper WC, Gaffey WR. Mortality of lead workers. J Occup Med 1975; 17: 100.

21. Andronikashvili EL, Mosulishvili LM, Belokobil'skiy AI, Kharabadze NE, Shonia NI. Human leukaemic cells. Determination of trace elements in nucleic acids and histones by neutron-activation analyses. Biochem J 1976; 157: 529-533.

22. StratiP, Pemmaraju N, Estrov Z. Cardenas-Turanzas M, Pierce S, Newberry KJ, Daver N, Cortes J, Kantarjian H, Verstovsek S. Clinical significance of microcytosis in patients with primary myelofibrosis. Leuk Res 2014; 38: 1212-1216.

23. Pardanani A, Finke C, Abdelrahman RA, Lasho TL, Tefferi A. Associations and prognostic interactions between circulating levels of hepcidin, ferritin and inflammatory cytokines in primary myelofibrosis. Am J Hematol 2013; 88: 312-316.

24. Tarkun P, Mehtap O, Atesoğlu EB, Geduk A, Musul MM, Hacihanefioglu A. Serum hepcidin and growth differentiation factor-15 (GDF-15) levels in polycythemia vera and essential thrombocythemia. Eur J Hematol 2013; 91: 228-235.

25. Anttila A, Pukkala E, Aitio A, Rantanen T, Karjalainen S. Update of cancer incidence among workers at a copper/nickel smelter and nickel refinery. Int Arch Occup Environ Health 1998; 71: 245-250.

26. Urinary level of nickel and acute leukaemia in Chinese children.Yang Y1, Jin XM, Yan CH, Tian Y, Tang JY, Shen XM.. PMID:19106127 [PubMed - indexed for MEDLINE]

27. Lloyd DR, Phillips DH, Carmichael PL. Generation of putative intrastrand cross-links and strand breaks in DNA by transition metal ion-mediated oxygen radical attack. Chem Res Toxicol 1997; 10: 393-400.

28. Sheppard PR, Speakman RJ, Ridenour G, Witten ML. Temporal variability of tungsten and cobalt in Fallon, Nevada. Environ Health Perspect 2007; 115: 715-719.

29. Fujii T. Presence of zinc in nucleoli and its possible role in mitosis. Nature 1954; 174: 1108-1109.

30. Woo YT, Lai DJ, Arcos JC, Argus MF. Chemical Induction of Cancer, Structural Bases and Biological Mechanisms 1988.

31. Simmer K, Pearson TC, Wheeler MJ, Thompson RP. Zinc status in polycythaemia. Eur J Hematol 1987; 38: 433-436.

32. Metzgeroth G, Kanders EM, Erben P, Hofmann WK, Hastka J. The role of zinc protoporphyrin measurement in the differentiation between primary myelofibrosis and essential thrombocythaemia. Ann Hematol 2011; 90: 389-394.